In addition, EGCG has been reported to suppress osteoclastogenesis by inhibiting downstream signaling of receptor activator nuclear factor kappa B (NFκB) (RANK) implying its role in preventing bone erosion in RA. Here, TNFRSF11A is linked to rheumatoid arthritis.